Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression.
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Revised diagnostic criteria of multiple sclerosis.
Immunogenicity and other problems associated with the use of biopharmaceuticals.
The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes.
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis.
Bilateral Multifocal Chorioretinitis and Optic Neuritis due to Epstein-Barr Virus: A Case Report.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Clinical impact of early brain atrophy in clinically isolated syndromes.
Pages
« first
‹ previous
…
497
498
499
500
501
502
503
504
505
…
next ›
last »